Comprehensive Analyses of Coagulation Parameters in Patients with Vascular Anomalies

Biomolecules. 2022 Dec 8;12(12):1840. doi: 10.3390/biom12121840.

Abstract

Background: Vascular anomalies comprise a diverse group of rare diseases with altered blood flow and are often associated with coagulation disorders. The most common example is a localized intravascular coagulopathy in venous malformations leading to elevated D-dimers. In severe cases, this may progress to a disseminated intravascular coagulopathy with subsequent consumption of fibrinogen and thrombocytes predisposing to serious bleeding. A separate coagulopathy is the Kasabach-Merritt phenomenon in kaposiform hemangioendothelioma characterized by platelet trapping leading to thrombocytopenia and eventually consumptive coagulopathy. Our previous work showed impaired von Willebrand factor and platelet aggregometry due to abnormal blood flow, i.e., in ventricular assist devices or extracorporeal membrane oxygenation. With altered blood flow also present in vascular anomalies, we hypothesized that, in particular, the von Willebrand factor parameters and the platelet function may be similarly impacted.

Methods: We prospectively recruited 73 patients with different vascular anomaly entities and analyzed their coagulation parameters.

Results: Acquired von Willebrand syndrome was observed in both of our patients with Kasabach-Merritt phenomenon. In six out of nine patients with complex lymphatic anomalies, both the vWF antigen and activity were upregulated. Platelet aggregometry was impaired in both patients with Kasabach-Merritt phenomenon and in seven out of eight patients with an arteriovenous malformation.

Conclusions: The analysis of coagulation parameters in our patients with vascular anomalies advanced our understanding of the underlying pathophysiologies of the observed coagulopathies. This may lead to new treatment options for the, in part, life-threatening bleeding risks in these patients in the future.

Keywords: Kasabach–Merritt phenomenon; coagulopathy; localized intravascular coagulopathy; platelet function; vascular anomalies; von Willebrand factor.

MeSH terms

  • Blood Coagulation Disorders* / etiology
  • Blood Coagulation Disorders* / physiopathology
  • Blood Coagulation*
  • Blood Platelets
  • Disseminated Intravascular Coagulation / etiology
  • Disseminated Intravascular Coagulation / physiopathology
  • Hemangioendothelioma / etiology
  • Hemangioendothelioma / physiopathology
  • Humans
  • Kasabach-Merritt Syndrome / etiology
  • Kasabach-Merritt Syndrome / physiopathology
  • Vascular Malformations* / complications
  • Vascular Malformations* / physiopathology
  • von Willebrand Factor / metabolism

Substances

  • von Willebrand Factor

Grants and funding

This research received no external funding.